Edited by Albert P Li (1 results)
Published by Academic Press an imprint of Elsevier, Registered Office:622 Indraprakash Building,21 Barakhamba Road,New Delhi-110 001, 2011
- Softcover
Seller: Vedams eBooks (P) Ltd, New Delhi, IndiaVedams eBooks (P) Ltd
Contact seller4-star sellerpbk. Contents Foreword Preface 1 Overview pharmacokinetic drug drug interactionsAlbert P Li and Malle Jurima Romet 2 Role of cytochrome P450 enzymes in Drug drug interactionsF Peter Guengerish 3 The liver as a target for chemical chemical interactionsJohn Michael Sauer Eric R Stine Lhanoo Gunawardhana Dwayne A Hill and I Glenn S…ipes 4 Application of human liver microsomes in metabolism based drug drug interactions in vitro in vivo correlations and the Abbott Laboratories experienceA David Rodrigues and Shekman L Wong 5 Primary hepatocyte cultures as an in Vitro experimental model for the evaluation of pharmacokinetic drug drug interactionsAlbert P Li 6 Liver slices as a model in drug metabolismJames L Ferrero and Klaus Brendel 7 Use of cDNA expressed human cytochrome P450 enzymes to study potential drug drug interactionsCharles L Crespi and Bruce W Penman 8 Pharmacokinetics of drug interactionsGregory L Kedderis 9 Experimental models for evaluating enzyme induction potential of new drug candidates in animals and humans and a strategy for their useThomas N Thompson 10 Metabolic drug drug interactions perspective from FDA medical and clinical pharmacology reviewersJohn Dikran Balian and Atiqur Rahman 11 Drug interactions perspectives of the Canadian drugs directorateMalle Jurima Romet 12 Overview of experimental approaches for study of drug metabolism and drug drug interactionsFrank J Gonzalez Index This volume presents a comprehensive review of drug-drug interactions from the perspectives of academia industry and government regulatory agencies The topics covered include drug metabolism enzymes toxicology in vitro mechanistic approaches and the regulatory perspectives of drug-drug interactions Drug-Drug Interactions Scientific and Regulatory perspectives is intended for professionals in the pharmaceutical industry in health care and in governmental regulatory agencies who are interested in understanding the mechanisms of drug-drug interactions predicting the interaction potential of new drugs and avoiding clinically significant drug-drug interactions in patients It should also be of interest to students and researchers in the areas of pharmacology toxicology pharmacokinetics and medicine 304 pp.